Clinical Trials Browser

Phase 3 × Rectal Neoplasms × trifluridine tipiracil drug combination × Clear all

NCT06850090 2026-04-28

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

Phase 3 Recruiting

Gastrointestinal

Rectal Neoplasms